Stoke Therapeutics STOK
NASDAQ STOK
$25.57 -0.44 (-1.69%)
As of: Oct 2, 2026 · 2:18 PM EDT

Stoke Therapeutics (STOK) Return on Assets [ROA] (2019 - 2026)

Updated

Stoke Therapeutics (STOK) recorded Return on Assets [ROA] of -50.50% in Q2 2026, down 62.96 percentage points from 12.46% a year earlier and down 10.28 percentage points from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics reported Return on Assets [ROA] of -5.97%, up 34.59 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of +13.89 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -40.56% in FY2024 (+6.83 pp), -47.39% in FY2023 (-5.22 pp), -42.17% in FY2022 (-10.10 pp) and -32.07% in FY2021 (-12.21 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q1 2024.
  • On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +13.39 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 67.61 percentage points in Q1 2025, against a drop of 62.96 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -40.22% (Q1 2026), -2.67% (Q4 2025) and 10.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - -50.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.50%
Mar 31, 2026 -40.22%
Dec 31, 2025 -2.67%
Sep 30, 2025 10.04%
Jun 30, 2025 12.46%
Mar 31, 2025 13.89%
Dec 31, 2024 -32.63%
Sep 30, 2024 -35.96%
Jun 30, 2024 -42.46%
Mar 31, 2024 -53.73%
Dec 31, 2023 -49.02%
Sep 30, 2023 -45.23%
Jun 30, 2023 -41.68%
Mar 31, 2023 -38.77%
Dec 31, 2022 -39.11%
Sep 30, 2022 -35.13%
Jun 30, 2022 -31.50%
Mar 31, 2022 -33.90%
Dec 31, 2021 -34.93%
Sep 30, 2021 -29.37%
API Access

Stoke Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=STOK&period=max&api_key=YOUR_API_KEY